Clinical Trials Collective Conditions Sleep 
The Cannigma
APRIL 12, 2023
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.
Project CBD
MARCH 21, 2023
She was upset with herself for being so careless and concerned that the condition would persist. For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. And it’s not just ringing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 2, 2021
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. brands, including Lord Jones. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
Cannabis Law Report
SEPTEMBER 14, 2021
Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. About Radicle Science.
Greencamp
FEBRUARY 17, 2019
Irritable bowel syndrome (IBS) is a collection of symptoms which create discomfort in the abdominal area, resulting in the inflammation of the digestive tract. Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS.
Cannabis Law Report
JULY 4, 2021
Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. When you use these substances, they can impact things like memory, sleep, mood, and pain. This is true if patients have the necessary medical conditions and if other treatments have not been effective.
The Cannigma
DECEMBER 12, 2022
And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming.
Expert insights. Personalized for you.
133 
Let's personalize your content